Open access peer-reviewed chapter

Contribution of Environmental Constituents in the Genomic Disruption of Cytokeratins

Written By

Vishnu Sharma, Tarun Kr. Kumawat, Garima Sharma, Rashi Garg and Manish Biyani

Submitted: September 15th, 2020 Reviewed: February 26th, 2021 Published: July 14th, 2021

DOI: 10.5772/intechopen.96877

Chapter metrics overview

209 Chapter Downloads

View Full Metrics

Abstract

Cytokeratins are keratinous protein and assist cells to reduce mechanical stress on the intracytoplasmic layer of epithelial tissue. There are several unspecified mutations in the epithelial layer that may induces by environmental mutagens and pathogens. The unspecified mutations in the epithelium surface also disrupt biology of skin at multiple different levels and cause innate keratinizing disorders. These serve as a root generator of neurohormones and neuropeptides which mainly partake in the disruption. Generally, all 54 unique genes of human keratin partake in mutations and cause cutaneous tissue fragility, skin hypertrophic, and malignant transformation. In this chapter, unspecific factors that involved in the pathogenesis of skin diseases and the ways by which such keratin changes might harness to alleviate different skin conditions are also included. Consequently, the contribution of environmental changes in the frontier of mutations or misregulations of the cytokeratin genes, is also cited here.

Keywords

  • keratins
  • skin barrier
  • keratinopathies
  • keratinocytes
  • protease allergens

1. Introduction

Cytokeratin is an intermediate keratinous protein found in the intracytoplasmic cytoskeleton of epithelial tissue. Cytokeratin possess essential components for the epithelium layer with diameters of 6 nm (microfilaments) to 25 nm (microtubules). The microfilaments or microtubules support cells to resist mechanical stress [1, 2, 3]. In the 1970s, the term ‘cytokeratin’ was derived through the protein characterization in the intermediate filament [4]. Later, in 2006, with the new systemic nomenclature, the terminology “cytokeratin” was termed as keratins. This nomenclature was under the nomenclature of the Human Genome Organization (HUGO) for both the gene and protein names [5, 6].

Keratin are the most complex protein in vertebrates and in filamentous form are essential epithelial cell structural stabilizers. That’s why; keratin is of unprecedented importance in genetics, embryology, pathology, and dermatology [7]. Keratin filaments are usually integrated with desmosomes and hemidesmosomes. They contribute: to the cohesion of the epithelial cells; for attachment of the basement membrane; and for epithelial connectivity tissue transition [8, 9]. Although few keratin structures/skeletons also found as scattered or dispersed between keratinous filaments in the cytoplasm of the internal parenchymatous organs. This behavior contributes to the (simple) unstratified epithelial membrane. These component sprouts increase as tonofilaments and transformed into a cornified stratified epithelial sheet [10].

Although, Keratin are classified into alpha and beta keratins according to the amount of sulfur content and structure [11]. Alpha (α) keratin form epithelial layers in all vertebrates [12, 13]. Configurationally, alpha (α) keratin has abundant amounts of the hydrophobic amino acids: methionine, phenylalanine, valine, isoleucine, and alanine. Due to the occurrence of these amino acids, alpha (α) keratin is extraordinary for its strength, elasticity, tiredness, insolubility, and durability [14]. Apart from the diversity of the epithelial keratins (‘soft’ or ‘cyto’); hair and nails are built from a very distinct subfamily of ‘hard’ or ‘trichocytic keratins’ [10, 15, 16, 17, 18]. Since they are enriched in stacked β pleated sheets and are known as corneous beta-protein” or “keratin-associated beta-protein [19, 20]. The epithelial keratins differ in their non-α-helical head and tail domain. This is due to the existence of high sulfur contents which is primarily responsible for the high filament linkage level of the keratin-associated protein [21, 22].

In filamentous form, keratin possesses a head-rod-tail structural arrangement with its basic polypeptide configuration consisting of a core alpha-helical coiled rod structure of about 310 amino acids in size. This central rod segment contains four helical structures interrupted by three short non-helical flexible reticulation/Linker regions [9, 12, 23]. These linker or reticulation regions flank by the complex, non-helical amino-terminal head and carboxy-terminal tail domains. In the rod domain, a heptad repeat of amino acid residues is present. Furthermore, near the middle of the domain, the “stutter” region is found and is a highly conserved segment among IFs. This area does not take part in the development of coiled-coil heterodimers but plays specific roles in the extension and rotation characteristics of keratins [24, 25]. At the beginning and end of the heptad repeat regions in the rod domain; are the highly conserved helix initiation motif (HIP) and helix termination peptides (HTP). Respectively, HIP & HTP, both consist of 20 amino acid sequences related to different keratin gene families [26, 27, 28]. The heteropolymeric structure of type I and type II keratin collectively generate a filamentous form. These are all aligned laterally with a scalable and parallel overlap and form KIFs through lateral stacking and polymerization of chains [9, 29, 30].

In cytokeratins, all of the intermediate filament proteins have the template/prototype structure that contains a central coiled-coil helix (310–350 amino acids). These are surrounded by the variable-length globular NH2-terminal head and COOH end-end tail domains [31, 32, 33]. Here, the keratin type I chain form a paired dimer with its type II counterpart and build an antiparallel fashion to a tetramer. Two tetramers transversely bind and resulted in a protofilament. Then, protofilaments are twisted into a keratin filament rope. Therefore, each keratin filament has a cross-section of 32 individual helical coils (Figure 1) [34, 35, 36, 37, 38]. The globular end-domains in most of the intermediate filament proteins contain all known sites for phosphorylation, glycosylation, and other relative activities [33, 39, 40, 41, 42].

Figure 1.

Differentiated Keratinocytes in Structure of Human Skin.

Usually, cytokeratin has an outstanding standard due to its high molecular diversity. The molecular weight of human keratins ranges from 44 to 66 kDa. In human, all 54 distinct functional keratin genes are found on chromosomes 12 & 17 and represent the typical intermediate filament category of epithelial cells. All keratin filaments are specifically bundled as tonofilaments in some but not all endothelium [43, 44]. In humans, all 54 distinct functional keratin genes are characterized as keratin type- I genes (17 epithelial and 11 hair keratin genes) and keratin type- II genes (20 epithelial keratins and 6 hair keratins) (Figure 2) [45, 46]. Type I keratin comprises the KRT9–KRT10, KRT12–KRT28, and KRT31–KRT40 (including KRT33a and KRT33b) genes, while type II keratin has KRT1–KRT8 (including KRT6a, KRT6b, and KRT6c) and KRT71–KRT86. Besides, the “stratified keratins” comprise KRT1 to KRT6 and KRT10 to KRT17 [10, 47, 48, 49, 50, 51].

Figure 2.

Ideogram and Phylogenetic description of Mammalian Keratin Chromosome (i.e. 12 & 17).

The human skin is the largest of the epithelial layers of the body and has a crucial strategic defensive position at the boundary between the interior and exterior environment of the body. Histologically, the skin is made of multi-layered, non-vascular, stratified epidermal squamous tissues which are extending to dense fibrous connective dermal tissues [52, 53]. For each cytoskeleton of the epithelial layer, there are three abundant filament systems available: actin-microfilament systems (MFs; 7–10 nm diameter; IFs; 10–12 nm diameter), interlinked microtubules, and (MTs; diameter 25 nm). Each filament system comprises a corresponding gene family with specially regulated cell-tissue regulators that encode each protein family [54]. Mutations in any cutaneous-associated keratin genes are increasingly apparent, which causes a host of hereditary skin disorders; and specified to weakened cell tissue integrity & damaged the skin [42, 55, 56, 57].

The regional specificity of keratin expression may add to the intrinsic specialization of regional keratinocyte stem cells. Disorders in keratin may be genetic or acquired. Several keratin mutations have been identified as a cause for many diseases in the skin and mucosal tissues [26, 58, 59, 60]. Beyond the biological roles, keratin expression describes cells not only as “epithelial,” but as distinctive even for characterize stages of cellular epithelial differentiation from embryonic to adult or internal maturation programs throughout growth. [10, 61, 62].

Mutations in the keratin amino acid sequence significantly affect the montage of keratin filaments [63, 64, 65]. Keratin genes repeat along with frameshift mutation and generate the pseudogenes. Approximately 87% of individuals’ keratin pseudogenes are equivalent to keratin genes 8 & 18 [66]. keratin pseudogenes continuously exchange their position on multiple chromosomes through crossing-overs or translocations [45, 67]. Mutations of keratin genes contribute to several human and murine skin disorders [68].

Keratinous genetic mutations cause various keratin disorders known as “Keratinopathies”. In the last decades, the spectrum of skin disorders has been increased enormously due to the abnormal function of structural proteins (keratins, filaggrin, loricrin, cornified cell envelope, etc.) [26, 47, 69, 70, 71, 72, 73]. It has also boost up or affected by deficient enzymes or transport proteins that are essential for lipid metabolism in the epidermis (cholesterol sulphatase, lipoxygenases, ABCA12, etc.). Mutations in epidermal keratins cause several skin diseases like congenital ichthyosis, epidermolytic ichthyosis, congenital bullous disease, corneal dystrophy, erythroderma, and pachyonychia congenital [74, 75, 76]. All the above diseases are due to mutation in the corneal keratin genes (KRT3, KRT12); mutation in simple epithelial keratin genes (KRT8/18, KRT19, KRT9); mutations in epithelial keratin genes (KRT6A, KRT6B, KRT6C, KRT16 or KRT17); mutations inKRT1 or KRT10 or basal layer keratinocytes genes (KRT5&KRT14) [77, 78].

In the epidermis and associated skin appendages, mutagenic cutaneous disorders are commonly termed as genodermatoses [79]. Keratin mutations represent keratin-related disorders including epidermolysis Bullosa Simplex (Keratin gene 5& 14), Keratinopathic Ichthyosis (Keratin gene l, 2 &10), Palmoplantar Keratoderma (Keratin gene 9), Pachyonychia Congenital (Keratin gene 6a,6b1,16 &17), and Monilethrix (Keratin gene 81, 83 & 86), etc. [18, 26, 80, 81, 82].

Epidermolysis bullosa is one of hereditary keratin disorder specified as mechanic-blistered skin. Epidermolysis bullosa is caused by desmoplakin or plakophilin type mutations in keratin genes KRT5 and KRT14 [83, 84]. In the manifestation of Epidermolysis bullosa, skin fragility reveals and can be increased in fluid-filled blister form or by the erosion of the skin. It causes failure in keratinization and affects the integrity or the ability of the skin to resist mechanical stresses. Hence, disease signs may extend for esophageal contraction, squamous carcinoma [85].

Epidermolysis Bullosa possess four main types: Epidermolysis Bullosa Simplex (EBS), Dystrophic Epidermolysis Bullosa (DEB), Junctional Epidermolysis Bullosa (JEB), and Kindler Syndrome (KS). In Epidermolysis Bullosa, all above disorders are inherited keratin disorder caused by mutations in Keratin genes 5 & 14 and plectin [86, 87]. The mutations in the gene of plectin are associated with muscular dystrophy. Symptomatically, Suprabasal epidermolysis causes fragility and blistering of skin or erosion by minor injury or friction (Rubbing or Scratching). Blistering may extend to mucous of the mouth with digestive tract and directly can affect the digestive system. Because of this, many infected children are poorly nourished and grow variably. The extended blistering cause irregular red patches of granulation sheath and rise to bleed regularly. In the enlargement of the disease, newborns lose essential metabolic nutriment and fluids. Consequently, granular sheath affects the respiratory tract and difficult to speaking and breathing [88, 89]. Besides, Kindler syndrome is a type of epidermolysis bullosa and causes skin blistering but often on the hands and feet. It generates scarring on the skin between the fingers and between the toes. Kindler syndrome is genetic dermatitis even though may also cause by ultraviolet (UV) rays and sunburn undoubtedly. The Kindler syndrome can expand on the outward of the oral cavity, throat, intestines, genitals, and urinary regions. Ultimately, the condition might be converted into squamous follicle melanoma [90, 91, 92, 93].

Keratinopathic ichthyosis is a generative disorder in the human that occurs by a mutation in Keratin genes (KRT1, KRT2, and KRT10). It exhibits anomalies in the membranous filaments and develops the spectrum of clinical manifestations [26, 94, 95]. Therefore, it is also known as superficial keratin keratodermas [60, 96]. This disorder manifests symptoms as scratched skin fragility, blister generation over flexural areas on erythroderma, and thick stratum corneum. The blistering and erythema in Neonates appear by birth though over time manifestation increases. Usually, Palmoplantar keratoderma also appears with Keratinopathic ichthyosis. It exhibits the thickening of the palm’s skin of the hands and soles of the feet [26, 97, 98].

Monilethrix is a pervasive innate disorder. It occurs due to mutation in the human keratin gene KRT86 and KRT81 [99, 100]. Clinically, Monilethrix is distinguished by dystrophic hair reduced region or with complete alopecia. Hair shaft deformation is defined by elliptical nodes that are commonly separated by reductions in skin color, by the appearance of scars, scratches, or rashes at the constricted regions [101, 102]. Infected hair also exhibits scarcities in the cortex of the skeletal hair shaft proteins, especially for trichocyte keratins. Rarely, hair possesses regrowth through adolescence or pregnancy [103, 104].

Pseudofolliculitis Barbae (PFB) and loose anagen hair syndrome (LAHS) are other hair disorders due to mutation in the keratin gene KRT75. Certain gene is located in the form of a cluster on the long arm of chromosome twelve. It originates with the follicular infection on the neck and beard region of the face [105, 106, 107, 108]. Sometimes disease also expands due to shaving on surrounding ingrown facial hairs, on the body wherever hair is shaved or plucked, including axilla, pubic area, and legs [18]. Apart from the cutaneous layer, nail dysplasias (Pachyonychia congenital) also take place in the hypertrophic portion of nails. It occurs due to mutation in the genes KRT6a, KRT16, and KRT107 [109, 110].

Ectodermal dysplasia is a separate one disorder similar to keratoderma or ichthyosis. It is associated with skin appendages bearing with the hair, nails, and sweat glands. Normally, this disorder is caused by a mutation in the KRT85 gene [111, 112].

Advertisement

2. Contribution of environmental constituents in mutation

Throughout the world, skin melanoma is the 19th most widespread cancer. Usually, almost all types of skin cancers are related to environmental factors including contact with immense ultraviolet radiation or due to sun exposure. Environmental mutagens may be synthetic or natural agents in nature [74, 113, 114, 115, 116]. these mutagens produce genetic mutations or expand mutational activities during the life span [117, 118]. Most of the environmental mutagens possess genotoxic effects on the next generation via germ cells and continue in the inherent form.

Besides ultraviolet radiation, other radioactive, heavy metals, organic solvents or chemicals, viruses, bacteria, etc. also perform a role to cause cell damage [119, 120, 121, 122]. Even, consumption of cigarette smoke, dietary contaminants including mycotoxin, aflatoxin B1, fat consumption, and unorganized stress are themselves integral environmental factors that contribute to cytokeratin disruptions [123]. All these agents are come in contact with the human through directly via skin & lungs or by ingestion. From this channel, these circulate in the body (blood, lymph glands, muscles, bones, tissues, and organs) and initiate mutations. In mutagenesis, these all mutagens penetrate directly to cellular and nuclear membranes and damage DNA by cross-linking (chemically gluing) two bases together. Sometimes, Mutagenesis is also caused by aberrant DNA methylation (epigenetic change) at the genomic level and post-translational modifications at the protein level. Finally, this results in genetic deficiencies cause.

Advertisement

3. Conclusion

Cytokeratins are essential protectors of epithelial structure found in the intracytoplasmic cytoskeleton of epithelial tissue. The occurrence of mutation in cytokeratin genes generates several genetic dermal disorders. In this genetic alteration, several environmental factors (ultraviolet, reactive oxygen species (ROS), deaminating agents, polycyclic aromatic hydrocarbon (PAH), ethylnitrosourea, azide, dyes, and heavy metals) take place as mutagen factors. The present chapter conclusively stated different cytokeratins disorders caused by environmental mutagens, i.e., synthetic or natural mutagens. In the end, based on environmental mutagens contributions, it can be stated that the genetic and epigenetic effects, arise/enhance through environmental mutagens/carcinogens, are the subject of innovative research.

References

  1. 1. Chatterjee S. Cytokeratins in Health and Disease. 2012; 3(1): 198-202.
  2. 2. Cooper D, Schermer A, Sun TT. Biology of disease. Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: Strategies, applications, and limitations. Laboratory Investigation. 1985; 52(3): 243-256.
  3. 3. Herrmann H, Bär H, Kreplak L, Strelkov S V., Aebi U. Intermediate filaments: From cell architecture to nanomechanics. Nature Reviews Molecular Cell Biology. 2007; 8(7): 562-573.
  4. 4. Franke WW, Schmid E, Osborn M, Weber K. Intermediate-sized filaments of human endothelial cells. Journal of Cell Biology. 1979; 81: 570-580.
  5. 5. Oriolo AS, Wald FA, Ramsauer VP, Salas PJI. Intermediate filaments: A role in epithelial polarity. Experimental Cell Research. 2007; 313: 2255-2264.
  6. 6. Schweizer J, Bowden PE, Coulombe PA, Langbein L, Lane EB, Magin TM, et al. New consensus nomenclature for mammalian keratins. Journal of Cell Biology. 2006; 174: 169-174.
  7. 7. Weathersby C, Mcmichael A. Brazilian keratin hair treatment: A review. Journal of Cosmetic Dermatology. 2013; 12(2): 144-148
  8. 8. Pan X, Hobbs RP, Coulombe PA. The expanding significance of keratin intermediate filaments in normal and diseased epithelia. Current Opinion in Cell Biology. 2013; 25:47e56.
  9. 9. Wang F, Zieman A, Coulombe PA. Skin Keratins. In: Methods in Enzymology. 2016; 568: 303-350.
  10. 10. Moll R, Divo M, Langbein L. The human keratins: biology and pathology. Histochemistry and cell biology. 2008; 129(6):705-33.
  11. 11. Kumawat TK, Sharma A, Sharma V, Chandra S. Keratin Waste: The Biodegradable Polymers. In: Keratin. 2018.
  12. 12. Bragulla HH, Homberger DG. Structure and functions of keratin proteins in simple, stratified, keratinized and cornified epithelia. In: Journal of Anatomy. 2009;214(4): 516-559.
  13. 13. Vandebergh W, Bossuyt F. Radiation and functional diversification of alpha keratins during early vertebrate evolution. Molecular Biology and Evolution. 2012;29(3):995-1004
  14. 14. Sharma V, Kumar Kumawat T, Seth R, Sharma A, Chandra S. A study on predominance of keratinophilic flora in soil of Jaipur, India. Journal of King Saud University - Science. 2020; 32(7): 2976-2981
  15. 15. Heid HW, Moll I, Franke WW. Patterns of expression of trichocytic and epithelial cytokeratins in mammalian tissues II. Concomitant and mutually exclusive synthesis of trichocytic and epithelial cytokeratins in diverse human and bovine tissues (hair follicle, nail bed and matrix, lingual papilla, thymic reticulum). Differentiation. 1988; 37(3):215-30.
  16. 16. Langbein L, Spring H, Rogers MA, Praetzel S, Schweizer J. Hair keratins and hair follicle-specific epithelial keratins. Methods in Cell Biology. 2004; 78:413-451.
  17. 17. Langbein L, Schweizer J. Keratins of the human hair follicle. International Review of Cytology. 2005;243: 1-78.
  18. 18. Schweizer J, Langbein L, Rogers MA, Winter H. Hair follicle-specific keratins and their diseases. Experimental Cell Research. 2007; 313(10): 2010-2020.
  19. 19. Alibardi L. Immunolocalization of alpha-keratins and feather beta-proteins in feather cells and comparison with the general process of cornification in the skin of mammals. Annals of Anatomy. 2013; 195(2): 189-198
  20. 20. Calvaresi M, Eckhart L, Alibardi L. The molecular organization of the beta-sheet region in Corneous beta-proteins (beta-keratins) of sauropsids explains its stability and polymerization into filaments. Journal of Structural Biology. 2016; 194 (3): 282-291.
  21. 21. Kreplak L, Aebi U, Herrmann H. Molecular mechanisms underlying the assembly of intermediate filaments. Experimental Cell Research. 2004; 301: 77 – 83.
  22. 22. Rogers MA, Langbein L, Praetzel-Wunder S, Winter H, Schweizer J. Human Hair Keratin-Associated Proteins (KAPs). International Review of Cytology. 2006; 251:209-63.
  23. 23. McKittrick J, Chen PY, Bodde SG, Yang W, Novitskaya EE, Meyers MA. The structure, functions, and mechanical properties of keratin. JOM. 2012; 64:449-468.
  24. 24. Banerjee S, Wu Q, Yu P, Qi M, Li C. In silico analysis of all point mutations on the 2B domain of K5/K14 causing epidermolysis bullosa simplex: a genotype-phenotype correlation. Molecular Biosystems. 2014; 10(10):2567-2577.
  25. 25. Yasukawa K, Sawamura D, McMillan JR, Nakamura H, Shimizu H. Dominant and recessive compound heterozygous mutations in epidermolysis bullosa simplex demonstrate the role of the stutter region in keratin intermediate filament assembly. Journal of Biological Chemistry. 2002; 277(26); 23670-23674.
  26. 26. Chamcheu JC, Siddiqui IA, Syed DN, Adhami VM, Liovic M, Mukhtar H. Keratin gene mutations in disorders of human skin and its appendages. Archives of Biochemistry and Biophysics. 2011;508(2):123-137.
  27. 27. Steinert PM. Structure, function, and dynamics of keratin intermediate filaments. Journal of Investigative Dermatology. 1993;100(6):729-734.
  28. 28. Schweizer J, Bowden PE, Coulombe PA, Langbein L, Lane EB, Magin TM, et al. New consensus nomenclature for mammalian keratins. Journal of Cell Biology. 2006; 174(2): 169-174.
  29. 29. Parry DAD. Hard α-keratin intermediate filaments: An alternative interpretation of the low-angle equatorial X-ray diffraction pattern, and the axial disposition of putative disulphide bonds in the intra-and inter-protofilamentous networks. International Journal of Biological Macromolecules. 1996; 19(1) 45-50.
  30. 30. Rasool M, Nawaz S, Azhar A, Wajid M, Westermark P, Baig SM, et al. Autosomal recessive pure hair and nail ectodermal dysplasia linked to chromosome 12p11.1-q14.3 without KRTHB5 gene mutation. European Journal of Dermatology. 2010; 20(4): 443-446.
  31. 31. Fraser RDB, MacRae TP, Suzuki E, Parry DAD, Trajstman AC, Lucas I. Intermediate filament structure: 2. Molecular interactions in the filament. Int J Biol Macromol. 1985; 7: 258-274.
  32. 32. Herrmann H, Aebi U. Intermediate Filaments: Structure and Assembly. Cold Spring Harb Perspect Biol. 2016;8(11): a018242.
  33. 33. Parry DAD, Fraser RDB. Intermediate filament structure: 1. Analysis of IF protein sequence data. Int J Biol Macromol. 1985; 7: 203-213
  34. 34. Bray DJ, Walsh TR, Noro MG, Notman R. Complete structure of an epithelial keratin dimer: Implications for intermediate filament assembly. PLoS ONE. 2015;10(7): e0132706.
  35. 35. Deb-Choudhury S, Plowman JE, Harland DP. Isolation and Analysis of Keratins and Keratin-Associated Proteins from Hair and Wool. In: Methods in Enzymology. 2016; 568: 279-301.
  36. 36. Fraser RDB, Parry DAD. Structural hierarchy of trichocyte keratin intermediate filaments. In: Advances in Experimental Medicine and Biology. 2018:57-70.
  37. 37. Kim S, Coulombe PA. Intermediate filament scaffolds fulfill mechanical, organizational, and signaling functions in the cytoplasm. Genes and Development. 2007; 21: 1581-1597.
  38. 38. Kornreich M, Avinery R, Malka-Gibor E, Laser-Azogui A, Beck R. Order and disorder in intermediate filament proteins. FEBS Letters. 2015; 589: 2464-2476.
  39. 39. Eriksson JE, Dechat T, Grin B, Helfand B, Mendez M, Pallari HM, et al. Introducing intermediate filaments: From discovery to disease. Journal of Clinical Investigation. 2009; 119:1763-1771.
  40. 40. Inagaki M, Inagaki N, Takahashi T, Takai Y. Phosphorylation-dependent control of structures of intermediate filaments: A novel approach using site- and phosphorylation state-specific antibodies. Journal of Biochemistry. 1997; 121: 407-414.
  41. 41. Omary MB, Coulombe PA, McLean WHI. Intermediate Filament Proteins and Their Associated Diseases. N Engl J Med. 2004; 351:2087-2100.
  42. 42. Omary MB, Ku NO, Liao J, Price D. Keratin modifications and solubility properties in epithelial cells and in vitro. Sub-cellular biochemistry. 1998.
  43. 43. Kumar A, Jagannathan N. Cytokeratin: A reviewon current concepts. Int J OrofacBiol. 2018; 2: 6-11
  44. 44. Steinert PM, Marekov LN, Fraser RDB, Parry DAD. Keratin intermediate filament structure. Crosslinking studies yield quantitative information on molecular dimensions and mechanism of assembly. Journal of Molecular Biology. 1993; 230(2): 436-452.
  45. 45. Coulombe PA, Omary MB. “Hard” and “soft” principles defining the structure, function and regulation of keratin intermediate filaments. Current Opinion in Cell Biology. 2002; 14: 110-122.
  46. 46. Jacob JT, Coulombe PA, Kwan R, Omary MB. Types I and II keratin intermediate filaments. Cold Spring Harbor Perspectives in Biology. 2018; 10(4): a018275.
  47. 47. Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology. 2002; 40(5): 403-439.
  48. 48. Coulombe PA, Lee CH. Defining keratin protein function in skin epithelia: Epidermolysis bullosa simplex and its aftermath. Journal of Investigative Dermatology. 2012; 132: 763-775.
  49. 49. Geisler N, Weber K. The amino acid sequence of chicken muscle desmin provides a common structural model for intermediate filament proteins. EMBO J. 1982; 1(12):1649-1656
  50. 50. Lane EB, McLean WHI. Keratins and skin disorders. Journal of Pathology. 2004; 204(4):355-366.
  51. 51. Parry DAD, Strelkov S V., Burkhard P, Aebi U, Herrmann H. Towards a molecular description of intermediate filament structure and assembly. Experimental Cell Research. 2007;313(10):2204-2216.
  52. 52. Günther J, Seyfert HM. The first line of defence: insights into mechanisms and relevance of phagocytosis in epithelial cells. Seminars in Immunopathology. 2018; 40(6):555-565
  53. 53. Slominski AT, Zmijewski MA, Skobowiat C, Zbytek B, Slominski RM, Steketee JD. Sensing the environment: Regulation of localand global homeostasis by the skin’s neuroendocrine system. Advances in Anatomy Embryology and Cell Biology. 2012; 212 1-115
  54. 54. Godsel LM, Hobbs RP, Green KJ. Intermediate filament assembly: dynamics to disease. Trends in Cell Biology. 2008; 18(1): 28-37.
  55. 55. DeStefano GM, Christiano AM. The genetics of human skin disease. Cold Spring Harbor perspectives in medicine. 2014;4(10):a015172.
  56. 56. Omary MB, Ku NO, Strnad P, Hanada S. Toward unraveling the complexity of simple epithelial keratins in human disease. Journal of Clinical Investigation. 2009; 119:1794-1805.
  57. 57. Djudjaj S, Papasotiriou M, Bülow RD, Wagnerova A, Lindenmeyer MT, Cohen CD, et al. Keratins are novel markers of renal epithelial cell injury. Kidney International. 2016; 89(4): 792-808
  58. 58. Rao RS, Patil S, Ganavi BS. Oral cytokeratins in health and disease. Journal of Contemporary Dental Practice. 2015; 15(1): 127-136
  59. 59. Rugg EL, Leigh IM. The keratins and their disorders. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 2004; 131C(1): 4-11.
  60. 60. Zhang L. Keratins in Skin Epidermal Development and Diseases. In: Keratin. 2018.
  61. 61. Deo PN, Deshmukh R. Pathophysiology of keratinization. Journal of Oral and Maxillofacial Pathology. 2018; 22(1): 86-91.
  62. 62. Shetty S, Gokul S. Keratinization and its disorders. Oman Medical Journal. 2012;27(5): 348-357.
  63. 63. Bertolino AP, Checkla DM, Heitner S, Freedberg IM, Yu D-W. Differential Expression of Type I Hair Keratins. J Invest Dermatol. 1990; 94(3):297-303.
  64. 64. Steinert PM. Keratins: Dynamic, flexible structural proteins of epithelial cells. Curr Probl Dermatol. 2001; 54:193-198
  65. 65. Szeverenyi I, Cassidy AJ, Cheuk WC, Lee BTK, Common JEA, Ogg SC, et al. The human intermediate filament database: Comprehensive information on a gene family involved in many human diseases. Human Mutation. 2008; 29: 351-360.
  66. 66. Hesse M, Zimek A, Weber K, Magin TM. Comprehensive analysis of keratin gene clusters in humans and rodents. Eur J Cell Biol. 2004; 83:19-26.
  67. 67. Hesse M, Magin TM, Weber K. Genes for intermediate filament proteins and the draft sequence of the human genome: Novel keratin genes and a suprisingly high number of pseudogenes related to keratin genes 8 and 18. J Cell Sci. 2001; 114:2569-2575
  68. 68. Pekny M, Lane EB. Intermediate filaments and stress. Experimental Cell Research. 2007; 313:2244-2254.
  69. 69. Lane EB, Alexander CM. Use of keratin antibodies in tumor diagnosis. Seminars in cancer biology. 1990; 1(3):165-179.
  70. 70. Moll R. Cytokeratins as markers of differentiation in the diagnosis of epithelial tumors. Sub-cellular biochemistry. 1998; 31:205-262.
  71. 71. Nagle RB. A review of intermediate filament biology and their use in pathologic diagnosis. Molecular Biology Reports. 1994; 19(1):3-21.
  72. 72. Oshima RG. Intermediate filaments: A historical perspective. Experimental Cell Research. 2007; 313(10):1981-1994.
  73. 73. Schaafsma HE, Ramaekers FC. Cytokeratin subtyping in normal and neoplastic epithelium: basic principles and diagnostic applications. Pathology annual. 1994;29(Pt 1):21-62.
  74. 74. Komine M. Regulation of Expression of Keratins and their Pathogenic Roles in Keratinopathies. In: Keratin. IntechOpen. 2018.
  75. 75. Smith FJD, Kreuser-Genis IM, Jury CS, Wilson NJ, Terron-Kwiatowski A, Zamiri M. Novel and recurrent mutations in keratin 1 cause epidermolytic ichthyosis and palmoplantar keratoderma. Clinical and Experimental Dermatology. 2019;44(5): 528-534
  76. 76. Zieman AG, Poll BG, Ma J, Coulombe PA. Altered keratinocyte differentiation is an early driver of keratin mutation-based palmoplantar keratoderma. Hum Mol Genet. 2019; 28(13
  77. 77. Agarwala M, Salphale P, Peter D, Wilson NJ, Pulimood S, Schwartz ME, et al. Keratin 17 mutations in four families from India with pachyonychia congenita. Indian J Dermatol. 2017; 62(4): 422-426.
  78. 78. Irvine AD, McKenna KE, Bingham A, Nevin NC, Hughes AE. A novel mutation in the helix termination peptide of keratin 5 causing epidermolysis bullosa simplex Dowling-Meara. J Invest Dermatol. 1997; 109: 815-816.
  79. 79. Babu NA, Rajesh E, Krupaa J, Gnananandar G. Genodermatoses. Journal of Pharmacy and Bioallied Sciences. 2015; 7(Suppl 1): S203–S206.
  80. 80. Arin MJ. The molecular basis of human keratin disorders. Human Genetics. 2009; 125:355-373.
  81. 81. Smith FJD. The molecular genetics of keratin disorders. American Journal of Clinical Dermatology. 2003; 4(5):347-364.
  82. 82. Uitto J, Richard G, McGrath JA. Diseases of epidermal keratins and their linker proteins. Experimental Cell Research. 2007; 313: 1995-2009.
  83. 83. Bolling MC, Lemmink HH, Jansen GHL, Jonkman MF. Mutations in KRT5 and KRT14 cause epidermolysis bullosa simplex in 75% of the patients. Br J Dermatol. 2011; 164(3):637-644
  84. 84. Fine J-D, Eady RAJ, Bauer EA, Bauer JW, Bruckner-Tuderman L, Heagerty A, et al. The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. Journal of the American Academy of Dermatology. 2008; 58(6): 931-950.
  85. 85. Irwin McLean WH, Moore CB. Keratin disorders: From gene to therapy. Human Molecular Genetics. 2011; 20(R2): 189-197.
  86. 86. Khani P, Ghazi F, Zekri A, Nasri F, Behrangi E, Aghdam AM, et al. Keratins and epidermolysis bullosa simplex. Journal of Cellular Physiology. 2018; 234(1):289-297.
  87. 87. Natsuga K. Epidermolysis Bullosa Simplex. In Rijeka: IntechOpen; 2013. p. Ch. 2. Available from: https://doi.org/10.5772/54609
  88. 88. Natsuga K, Nishie W, Shinkuma S, Arita K, Nakamura H, Ohyama M, et al. Plectin Deficiency Leads to Both Muscular Dystrophy and Pyloric Atresia in Epidermolysis Bullosa Simplex. Human Mutation. 2010; 31(10): E1687–E1698.
  89. 89. Siañez-González C, Pezoa-Jares R, Salas-Alanis JC. Congenital epidermolysis bullosa: A review. ActasDermo-Sifiliograficas. 2009; 100(10):842-856
  90. 90. Alper JC, Baden HP, Goldsmith LA. Kindler’s syndrome. Arch Dermatol. 1978; 114(3): 457.
  91. 91. Lai-Cheong JE, Tanaka A, Hawche G, Emanuel P, Maari C, Taskesen M, et al. Kindler syndrome: A focal adhesion genodermatosis. British Journal of Dermatology. 2009; 160(2):233-242.
  92. 92. Souldi H, Bajja MY, Mahtar M. Kindler syndrome complicated by invasive squamous cell carcinoma of the palate. Eur Ann Otorhinolaryngol Head Neck Dis. 2018; 135(1):59-61.
  93. 93. Youssefian L, Vahidnezhad H, Barzegar M, Li Q, Sotoudeh S, Yazdanfar A, et al. The Kindler syndrome: a spectrum of FERMT1 mutations in Iranian families. The Journal of investigative dermatology. 2015; 135: 1447-50.
  94. 94. Hotz A, Oji V, Bourrat E, Jonca N, Mazereeuw-Hautier J, Betz RC, et al. Expanding the clinical and genetic spectrum of KRT1, KRT2 and KRT10 mutations in keratinopathic ichthyosis. ActaDermato-Venereologica. 2016; 96(4):473-478
  95. 95. Ross R, DiGiovanna JJ, Capaldi L, Argenyi Z, Fleckman P, Robinson-Bostom L. Histopathologic characterization of epidermolytic hyperkeratosis: A systematic review of histology from the National Registry for Ichthyosis and Related Skin Disorders. J Am Acad Dermatol. 2008; 59: 86-90.
  96. 96. Oji V, Tadini G, Akiyama M, Blanchet Bardon C, Bodemer C, Bourrat E, et al. Revised nomenclature and classification of inherited ichthyoses: Results of the First Ichthyosis Consensus Conference in Sorze 2009. Journal of the American Academy of Dermatology. 2010; 63(4) 607-641
  97. 97. Dev T, Mahajan V, Sethuraman G. Hereditary palmoplantar keratoderma: A practical approach to the diagnosis. Indian Dermatology Online Journal. 2019; 10(4): 365
  98. 98. Terron-Kwiatkowski A, Terrinoni A, Didona B, Melino G, Atherton DJ, Irvine AD, et al. Atypical epidermolytic palmoplantar keratoderma presentation associated with a mutation in the keratin 1 gene. British Journal of Dermatology. 2004; 150(6): 1096-1103
  99. 99. Ferreira MAT, Gonzales JFO, Diniz BL, Floriani MA, Bau AEK, Rosa RCM, et al. Description of clinical aspects and microscopy of the hair shaft of a carrier of familial monilethrix. JornalBrasileiro de Patologia e Medicina Laboratorial. 2018; 54(5): 333-335.
  100. 100. Van Steensel MA, Steijlen PM, Bladergroen RS, Vermeer M, van Geel M. A missense mutation in the type II hair keratin hHb3 is associated with monilethrix. Journal of medical genetics. 2005; 42(3): e19.
  101. 101. Horev L, Glaser B, Metzker A, Ben-Amitai D, Vardy D, Zlotogorski A. Monilethrix: Mutational hotspot in the helix termination motif of the human hair basic keratin 6. Human Heredity. 2000; 50: 325-330
  102. 102. Vikramkumar AG, Kuruvila S, Ganguly S. Monilethrix: A rare hereditary condition. Indian J Dermatol. 2013; 58: 243
  103. 103. Farooq M, Ito M, Naito M, Shimomura Y. A case of monilethrix caused by novel compound heterozygous mutations in the desmoglein 4 (DSG4) gene. British Journal of Dermatology. 2011; 165(2):425-431.
  104. 104. Ferrando J, Galve J, Torres-Puente M, Santillán S, Nogués S, Grimalt R. Monilethrix: A new family with the novel mutation in KRT81 gene. International Journal of Trichology. 2012; 4(1): 53-55.
  105. 105. Avhad G, Ghuge P, Jerajani H. Loose anagen hair syndrome. Indian Dermatology Online Journal. 2014;5(4):548-9.
  106. 106. Agrawal D, Amin S, Adil M, Priya A. Uncombable hair syndrome with loose anagen syndrome: A rare association. Indian Journal of Paediatric Dermatology. 2020; 21(4):332-334.
  107. 107. Srinivas SM. Loose Anagen Hair Syndrome. International journal of trichology. 2015;7(3):138-9.
  108. 108. Ogunbiyi A. Pseudofolliculitisbarbae; current treatment options. Clinical, Cosmetic and Investigational Dermatology. 2019; 12: 241-247
  109. 109. Shamsher MK, Navsaria HA, Stevens HP, Ratnavel RC, Purkis PE, Keisell DP, et al. Novel mutations in keratin 16 gene underly focal non-epidermolytic palmoplantar keratoderma (NEPPK) in two families. Human Molecular Genetics. 1995; 4:1875-1881.
  110. 110. Smith FJD, Fisher MP, Healy E, Rees JL, Bonifas JM, Epstein EH, et al. Novel keratin 16 mutations and protein expression studies in pachyonychia congenita type 1 and focal palmoplantar keratoderma. Exp Dermatol. 2000; 9:170-177
  111. 111. Prashanth S, Deshmukh S. Ectodermal Dysplasia: A Genetic Review. International Journal of Clinical Pediatric Dentistry. 2012; 5(3) 197-202
  112. 112. Wright JT, Fete M, Schneider H, Zinser M, Koster MI, Clarke AJ, et al. Ectodermal dysplasias: Classification and organization by phenotype, genotype and molecular pathway. American Journal of Medical Genetics, Part A. 2019; 179(3):442-447
  113. 113. Bernerd F, Del Bino S, Asselineau D. Regulation of keratin expression by ultraviolet radiation: Differential and specific effects of ultraviolet B and ultraviolet A exposure. Journal of Investigative Dermatology. 2001; 117(6): 1421-1429.
  114. 114. Lopez A, Liu L, Geskin L. Molecular Mechanisms and Biomarkers of Skin Photocarcinogenesis. In 2018.
  115. 115. Narayanan DL, Saladi RN, Fox JL. Ultraviolet radiation and skin cancer. International Journal of Dermatology. 2010;49: 978-986.
  116. 116. Saladi RN, Persaud AN. The causes of skin cancer: A comprehensive review. Drugs of Today. 2005; 41(1): 37-53.
  117. 117. Ralston A. Environmental mutagens, cell signalling and DNA repair. Nature Education. 2008; 1(1): 114.
  118. 118. Yagi T. A perspective of Genes and Environment for the development of environmental mutagen research in Asia. Genes and Environment. 2017; 39: 23.
  119. 119. Sesto A, Navarro M, Burslem F, Jorcano JL. Analysis of the ultraviolet B response in primary human keratinocytes using oligonucleotide microarrays. Proceedings of the National Academy of Sciences of the United States of America. 2002; 99(5): 2965-2970.
  120. 120. D’Orazio J, Jarrett S, Amaro-Ortiz A, Scott T. UV radiation and the skin. International Journal of Molecular Sciences. 2013; 14:12222-12248.
  121. 121. Chatterjee N, Walker GC. Mechanisms of DNA damage, repair, and mutagenesis. Environmental and Molecular Mutagenesis. 2017; 58: 235-263.
  122. 122. Hartwig A, Arand M, Epe B, Guth S, Jahnke G, Lampen A, et al. Mode of action-based risk assessment of genotoxic carcinogens. Archives of Toxicology. 2020; 94: 1787-1877.
  123. 123. Minamoto T, Mai M, Ronai Z. Environmental factors as regulators and effectors of multistep carcinogenesis. Carcinogenesis. 1999 Apr;20(4):519-27.

Written By

Vishnu Sharma, Tarun Kr. Kumawat, Garima Sharma, Rashi Garg and Manish Biyani

Submitted: September 15th, 2020 Reviewed: February 26th, 2021 Published: July 14th, 2021